| Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax YW Wang, CH Tsai, CC Lin, FM Tien, YW Chen, HY Lin, M Yao, YC Lin, ... Annals of Hematology 99, 501-511, 2020 | 71 | 2020 |
| Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in … CY Chen, FM Tien, WH Sheng, SY Huang, M Yao, JL Tang, W Tsay, ... International journal of antimicrobial agents 49 (3), 272-281, 2017 | 64 | 2017 |
| Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients FM Tien, HA Hou, CH Tsai, JL Tang, CY Chen, YY Kuo, CC Li, CT Lin, ... European journal of haematology 101 (1), 86-94, 2018 | 42 | 2018 |
| GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute … FM Tien, HA Hou, CH Tsai, JL Tang, YC Chiu, CY Chen, YY Kuo, ... Blood cancer journal 8 (9), 87, 2018 | 40 | 2018 |
| Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML CH Tsai, JL Tang, FM Tien, YY Kuo, DC Wu, CC Lin, MH Tseng, YL Peng, ... Blood Advances 5 (10), 2456-2466, 2021 | 39 | 2021 |
| Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008–2013 CY Chen, WH Sheng, FM Tien, PC Lee, SY Huang, JL Tang, W Tsay, ... Journal of Microbiology, Immunology and Infection 53 (1), 106-114, 2020 | 38 | 2020 |
| Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA FM Tien, HA Hou, JL Tang, YY Kuo, CY Chen, CH Tsai, M Yao, CT Lin, ... Haematologica 103 (11), e510, 2018 | 37 | 2018 |
| Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients CH Tsai, CY Yao, FM Tien, JL Tang, YY Kuo, YC Chiu, CC Lin, MH Tseng, ... EBioMedicine 40, 240-250, 2019 | 30 | 2019 |
| Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan CY Chen, FM Tien, A Cheng, SY Huang, WC Chou, M Yao, JL Tang, ... BMC gastroenterology 18, 1-8, 2018 | 30 | 2018 |
| Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies CY Chen, A Cheng, FM Tien, PC Lee, HF Tien, WH Sheng, YC Chen BMC infectious diseases 19, 1-9, 2019 | 25 | 2019 |
| Automatic bone marrow cell identification and classification by deep neural network TC Yu, WC Chou, CY Yeh, CK Yang, SC Huang, FM Tien, CY Yao, ... Blood 134, 2084, 2019 | 21 | 2019 |
| Hepatitis B reactivation during treatment of tyrosine kinase inhibitors-Experience in 142 adult patients with chronic myeloid leukemia. YH Wang, JD Liang, WH Sheng, FM Tien, CY Chen, HF Tien Leukemia Research 81, 95-97, 2019 | 21 | 2019 |
| Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de … MY Lo, XCH Tsai, CC Lin, FM Tien, YY Kuo, WH Lee, YL Peng, MC Liu, ... American journal of hematology 98 (5), 760-769, 2023 | 17 | 2023 |
| Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML XCH Tsai, KJ Sun, MY Lo, FM Tien, YY Kuo, MH Tseng, YL Peng, ... Blood Cancer Journal 13 (1), 4, 2023 | 16 | 2023 |
| Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience YW Wang, XCH Tsai, HA Hou, FM Tien, JH Liu, WC Chou, BS Ko, ... Annals of Hematology 101, 349-358, 2022 | 16 | 2022 |
| Safety, feasibility, and effects of short-term calorie reduction during induction chemotherapy in patients with diffuse large B-cell lymphoma: a pilot study CC Tang, TC Huang, FM Tien, JM Lin, YC Yeh, CY Lee Nutrients 13 (9), 3268, 2021 | 13 | 2021 |
| Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities FM Tien, HH Lu, SY Lin, HC Tsai Journal of Biomedical Science 30 (1), 3, 2023 | 12 | 2023 |
| Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission FM Tien, CH Tsai, SC Huang, JH Liu, CY Chen, YY Kuo, YK Chuang, ... Bone Marrow Transplantation 57 (1), 95-105, 2022 | 10 | 2022 |
| Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification WH Lee, MT Tsai, CH Tsai, FM Tien, MY Lo, MH Tseng, YY Kuo, MC Liu, ... Blood Cancer Journal 13 (1), 120, 2023 | 7 | 2023 |
| Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 … WH Lee, CC Lin, CH Tsai, FM Tien, MY Lo, SC Ni, M Yao, MH Tseng, ... American Journal of Hematology 98 (3), 398-407, 2023 | 7 | 2023 |
Hou Hsin-AnNational Taiwan University Hospital在 ntu.edu.tw 的电子邮件经过验证
Hou Hsin-AnNational Taiwan University Hospital在 ntu.edu.tw 的电子邮件经过验证
Chien-Yuan ChenNational Taiwan University Hospital在 ntu.edu.tw 的电子邮件经过验证